Ergocalciferol (Vitamin D2) vs. Cholecalciferol (Vitamin D3) Food Fortification: Comparative Efficiency in raising 25OHD Status in Caucasian & Asian Women and Mechanisms of Action (D2-D3 Study)

niversity of Surrey (UK)0 个研究点目标入组 355 人开始时间: 2011年7月29日最近更新: 2018年1月8日

适应症

试验速览

暂无简介。

•1. Female, aged 20-64 years
•2. Caucasian ethnic origin or partly-veiled women of South Asian (i.e. India, Pakistan, Bangladesh) or Arabian ethic origin
•3. Body Mass Index 18-30 kg/m2
•4. Pre-menopausal OR five years post-menopause
•5. Written informed consent

•1. Currently receiving treatment for medical conditions likely to affect vitamin D metabolism
•2. Regular use of sunbeds
•3. Having a sun holiday one month prior to commencing the trial or plans for a sun holiday within the study period
•4. Use of vitamin supplements containing vitamin D
•5. Consumption of alcohol above recommended levels (>14units per week)
•6. Those following a weightreducing diet or under dietary restriction (except vegetarianism)
•7. Known intolerance/allergy to the constituent ingredients of the intervention products
•8. Clinically significant haematological abnormalities other than mild anaemia (Hb>10.0g/dl)
•9. Active malignancy
•10. Postmenopause less than five years
•11. Pregnant or planning a pregnancy during the study period
•12. Breastfeeding mothers

发起方

niversity of Surrey (UK)